Clinical evaluation of Lasunadi Vati and Pippaladyasava in the management of Agnimandya.

Central Council for Research in Ayurvedic Sciences. New-Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年2月6日

试验速览

暂无简介。

•1.Patients of either sex with age between 18 and 60 years.
•2.Patients having any six sign and symptoms of Agnimandya out of 10 along with reduced Abhyavaharan Shakti, (capacity to eat), Jarana Shakti (capacity to digest), and Ruchi (appetite) for the past one week. Avipaka, Aruchi, Udaragaurava, Shirogaurava, Praseka, Chhardi, Kasa, Shwasa, Gatrasada, Malavarodha.
•3.Willing to participate in the study.

•1.Patients of age <18 years and >60 years.
•2.Patients in whom Agnimandya is caused due to intake of medicine.
•3.Patients having Tikshagni (hyper functioning of digestion and metabolic activities) and Samagni (moderate Agni)
•4.Patients having any established disease of Gastro-intestinal tracts.
•5.Immuno compromised states and patients with systemic infections or known cases of AIDS, HIV, STD etc.
•6.Patients with severe/history of cardiac, hepatic, cerebrovascular disease, pulmonary dysfunction, malignancy, chronic uncontrolled systemic diseases or renal disorder (S. Creatinine >1.2 mg/dl) etc or poorly controlled Hypertension (Blood pressure more than 160/100mm of Hg), uncontrolled Diabetes Mellitus (HbA1c >= 8), or any other serious medical illness.
•7.Patients on medication with corticosteroids or any other drugs that may have an influence on the outcome of the study.
•8.History of hypersensitivity to the trial drug or any of its ingredients.
•9.Patients who have completed participation in any other clinical trial during the past three months.
•10. Any other condition, which the Investigator thinks, may jeopardize the study.

发起方

Central Council for Research in Ayurvedic Sciences. New-Delhi